Deutsche Bank Downgrades MAP Pharmaceuticals (MAPP) to Hold, Lowers Estimates & Price Target
Tweet Send to a Friend
Deutsche Bank downgrades MAP Pharmaceuticals (Nasdaq: MAPP) to Hold. Price target lowered from $15 to $5.
Deutsche analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Deutsche analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
